Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks close higher on Wall St, airlines bounce

Thu, 28th Jan 2021 09:16

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Airlines gain on short squeeze in AAL

* EU warns it could block vaccine exports

* Spike in volatility hits equities
(Updates to market close)

By Sruthi Shankar and Joice Alves

Jan 28 (Reuters) - European stocks closed higher on Thursday
as a bounce in Wall Street stocks, gains in airlines and upbeat
earnings reports drove a reversal of early losses across
markets.

After falling as much as 2% in morning trade, the
pan-European STOXX 600 rose 0.1% by the close, leaving
the benchmark with small gains for the year.

The German DAX gained 0.3%, France's CAC 40
was up 0.9% and Britain's exporter-heavy FTSE fell 0.6%,
coming under pressure from a rise in the pound.

Stocks globally saw a spike in volatility this week as a
retail trading frenzy hit markets in the United States, Europe
and Asia, inflating value in certain stocks that major hedge
funds have bet against.

Wall Street jumped on gains in technology stocks, while
American Airlines surged more than 20% at one point
after the U.S. carrier was mentioned on Reddit's WallStreetBets
forum following its results.

European travel names like Lufthansa, TUI
and British Airways-owner IAG rose between 4.7% and
7.2%. Wizz Air and easyJet rose more than 4.5%
each despite posting a double-digit decline in fourth-quarter
revenue.

"UK airlines are tracking a short squeeze in American
Airlines brought on by r/WallStreetBets after it released Q4
earnings," said Jasper Lawler, head of research at LCG. "AA has
abnormally high short interest but other airlines do too given
the state the industry is in."

Other European stocks that were highly bid this week, like
CD Projekt, Ambu and Varta,
extended gains, while Nokia tumbled 13%.

Investors looked past strong earnings from Apple
and Facebook as well as the U.S. Federal Reserve's pledge
to stick to loose monetary policy as worries about slow rollout
of COVID-19 vaccines and more curbs in Europe dampened the mood.

"With valuations at levels already pricing in much of the
recovery from a pandemic that is far from over, these
corrections are always possible," Ian Williams, economics and
strategy research analyst at Peel Hunt said in a note.

Germany is preparing entry restrictions for travellers from
Britain, Brazil and South Africa, and its health minister
expects the current shortage of coronavirus vaccines to continue
well into April.

Meanwhile, the European Union warned drug companies such as
AstraZeneca that it would use all legal means or even
block exports unless they agreed to deliver shots as promised.

The world's largest spirits maker Diageo rose 3%
after it reported a surprise rise in underlying net sales growth
in the first half of the year, helped by strong U.S. demand.

Swedish medical equipment maker Getinge jumped 9%
after reporting strong quarterly results as it saw a spike in
demand in 2020 for ventilators and other advanced life support
equipment due to the pandemic.
(Reporting by Sruthi Shankar in Bengaluru and Joice Alves in
London; Editing by Arun Koyyur and Mark Heinrich)

More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.